Anheuser-Busch InBev SA NV BUD Stock Price, Quote & News

A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Anheuser-Busch InBev SA/NV produces, distributes, markets, and sells beer and beverages. The company was founded in 1366 and is headquartered in Leuven, Belgium.

Shares fell below their 50-day moving average and 21-day lines late last week. Impact from the Bud Light boycotts sent shares down 21% from their 2023 high of 67.09 at the end of March to a low of 52.93 on May 31. BUD stock has recovered slightly from its lows, but is still down nearly 6.5% for the year. The Gates Foundation Trust saw its Berkshire Hathaway Class B holdings increase by $2.49 billion during the quarter.

• An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted.
• A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.
• The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
• These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured.
• Microsoft co-founder Bill Gates’ foundation recently bought 1.7 million shares of Bud Light parent company Anheuser-Busch as the company struggles amid controversy.
• Securities products offered by Open to the Public Investing are not FDIC insured.

Alternative Assets.Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in an Open to the Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets.

Modelo dethrones Bud Light as America’s best-selling beer for 2023

These forward-looking statements are based on BioNTech’s current expectations and speak only as of the date hereof. The COVID-19 vaccines (COMIRNATY®) by Pfizer and BioNTech are based on BioNTech’s proprietary mRNA technology and were developed by both companies. Meanwhile Tilray’s alcoholic beverage revenue soared 33% to $95 million. The addition of its newly acquired brands from AB InBev will triple the size of Tilray’s beer business, from 4 million to 12 million cases.

JSI and Jiko Bank are not affiliated with Public Holdings, Inc. (“Public”) or any of its subsidiaries. To manage these risks, Anheuser-Busch InBev has implemented robust risk management strategies. This includes closely monitoring consumer trends, diversifying its product portfolio, maintaining strong relationships with regulators and policymakers, and conducting thorough market research.

Tilray’s Beer Business Expands Nationally, Starting In This State

One share of BUD stock can currently be purchased for approximately $56.87. Click the link below and we’ll send you MarketBeat’s guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. The products discussed herein may have different labeling in different countries. This information—including product information—is intended only for residents of the United States.

By staying agile and adaptable, the company can navigate potential challenges and seize opportunities in the market. In the European Union, the Omicron XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) has also received marketing authorization by the European Commission for individuals 6 months of age and older on August 31, 2023. Pfizer and BioNTech have submitted data for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine to other regulatory authorities around the world. Anheuser-Busch InBev faces competition from global and local players in its operating markets.

Today’s Trading

The consensus among Wall Street research analysts is that investors should “hold” BUD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BUD, but not buy additional shares or sell existing shares. The company’s global presence and diverse portfolio of brands give it a significant edge in the market. Anheuser-Busch InBev has successfully built a strong brand image and customer loyalty through effective marketing campaigns and sponsorships of major sporting events.

Stricter regulations on alcohol advertising and labeling, increased taxes, or limitations on distribution can hinder market growth and increase costs. Anheuser-Busch InBev must closely monitor and adapt to these regulatory changes to mitigate their impact. Anheuser-Busch InBev operates in the highly competitive brewing industry. Intense competition, evolving consumer preferences, and regulatory challenges characterize the industry. Despite these factors, Anheuser-Busch InBev has established itself as a dominant player with a solid competitive advantage. The company eked out positive adjusted free cash flow (FCF) of $1.26 million last fiscal year, compared to negative adjusted FCF of $187.6 million in fiscal 2022.

Since 1988 it has more than doubled the S&P 500 with an average gain of +24.32% per year. These returns cover a period from January 1, 1988 through July 31, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.

Tilray’s net revenue from cannabis declined 7.6% last fiscal year (down 2% at constant currencies) to $220 million. AB InBev–the world’s largest brewer, which makes more than 500 brands including Corona, Stella Artois and Hoegaarden–said last month that its second-quarter revenue had plummeted 10.5% in the U.S. following backlash from its partnership with Mulvaney. A quarterly cash dividend of $0.54 per share of Class A Common Stock. The quarterly cash dividend was payable on June 2, 2022 to stockholders of record on May 3, 2022.

Time to Upgrade!

Emerging economies present the untapped potential for the company to introduce its brands to a growing middle class with increasing disposable income. Anheuser-Busch InBev can further expand its market share by tailoring its products to suit local preferences and investing in distribution networks. It is worth noting that the brewing industry is subject to regulatory and political factors that can impact operations. This includes regulations related to alcohol advertising, labeling, taxation, and changes in consumer preferences toward healthier alternatives.

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer.

Tilray makes deeper bet into beers, will buy 8 brands from Anheuser-Busch

Anheuser-Busch InBev also pays a dividend which is excellent for investors looking for passive income. This demonstrates the company’s commitment to returning value to its shareholders. Assuming the acquisition closes as planned before the end of 2023, those brands should nicely complement a bank lets its customers choose a personal identification number Tilray’s existing beer varieties, which include SweetWater Brewing, Montauk Brewing, Alpine Beer, and Green Flash Brewing. The company also owns spirits producer Breckenridge Distillery, and offers CBD-infused sparkling non-alcoholic cocktails through its Happy Flower brand.

• This includes closely monitoring consumer trends, diversifying its product portfolio, maintaining strong relationships with regulators and policymakers, and conducting thorough market research.
• According to a recent filing with the Securities and Exchange Commission (SEC), the Bill & Melinda Gates Foundation Trust revealed it had bought 1.7 million AB InBev shares in the second quarter, which had a value of almost $96.6 million.
• Headquartered in Leuven, Belgium, the company operates in over 50 countries and has a vast portfolio of well-known beer brands.
• A quarterly cash dividend of $0.54 per share of Class A Common Stock.

For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering https://1investing.in/ statement filed with the SEC has been qualified by the SEC. An indication of interest to purchase securities involves no obligation or commitment of any kind. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system.

In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Anheuser-Busch InBev, or AB InBev, has been acquisitive, having made transformative deals for Interbrew and Anheuser-Busch, and more recently acquiring Grupo Modelo, Oriental Brewery, and SABMiller.

The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. Anheuser-Busch InBev is the largest brewer in the world and one of the world’s top five consumer product companies, as measured by EBITDA.

Anheuser-Busch InBev actively monitors and adapts to these regulatory and industry trends to mitigate potential risks. Biopharmaceutical New Technologies (BioNTech) is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, OncoC4, Regeneron, Sanofi, and Pfizer. Stocks and ETFs.Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC.

Get this delivered to your inbox, and more info about our products and services. Over the past six months, the company’s shares have shed more than 9% of their value. Tilray Brands, a major cannabis company, is tapping into the beverage industry with recent acquisitions from Molson Coors and Anheuser-Busch. Bill Gates purchased 1.7 million shares of Anheuser-Busch, valued at $95 million, in the second quarter.